ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 79 filers reported holding ARCUS BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,147,000 | -42.7% | 270,000 | -10.0% | 0.09% | -43.1% |
| Q1 2019 | $3,747,000 | +16.0% | 300,000 | 0.0% | 0.15% | +27.5% |
| Q4 2018 | $3,231,000 | -22.7% | 300,000 | 0.0% | 0.12% | +10.1% |
| Q3 2018 | $4,182,000 | +13.9% | 300,000 | 0.0% | 0.11% | +39.7% |
| Q2 2018 | $3,672,000 | -20.7% | 300,000 | 0.0% | 0.08% | +34.5% |
| Q1 2018 | $4,632,000 | – | 300,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |